Daewoong Pharmaceutical Secures Approval for 'Enblo' in Ecuador
Daewoong Pharmaceutical's new diabetes treatment, 'Enblo', has taken its first step into the global market. The company announced on the 14th that its diabetes medication 'Enblo' (active ingredient: inavogliflozin) received approval …